Treatment group | FOLFOX + placebo | XELOX + placebo | FOLFOX + bevacizumab | XELOX + bevacizumab |
N | 351 | 350 | 349 | 350 |
Both placebo groups | Both bevacizumab groups | |||
PFS, median (months) | 8.0 | 9.4 (p = .0023) | ||
OS, median (months) | 19.9 | 21.3 | ||
Response rate, percent | 38 (49)* | 38 (47)* |
Do you want to add Medilib to your home screen?